Giovanni Caforio Appointed as Operating Advisor to CD&R Funds
CD&R has appointed Giovanni Caforio, the current Chair of Novartis and former CEO of Bristol Myers Squibb (BMS), as an Operating Advisor. His extensive experience in the biopharmaceutical industry is expected to support CD&R funds in evaluating healthcare investment opportunities and working with portfolio companies globally. Caforio has a 35-year career, including leadership roles at Abbott Laboratories and BMS where he oversaw significant growth, launching 12 new medicines and tripling revenue during his tenure as CEO from 2015 to 2023. CD&R's Co-President Dave Novak emphasized the value of partnering with industry leaders like Caforio for investment success in healthcare. CD&R Partner Eric Rouzier highlighted that Caforio’s expertise aligns well with their long-term strategy, emphasizing innovation and operational excellence in a dynamic sector.
Topics: Healthcare Leadership Private Equity